Nebivolol Alleviates Vascular Endothelial Insulin Resistance by Inhibiting Endoplasmic Reticulum Stress.

Li, Xinxin; Li, Qiuping; Wu, Lijun; Wang, Yan

Li, Xinxin; Li, Qiuping; Wu, Lijun; Wang, Yan.

Affiliation

Li X; Department of Pharmacology, Shanxi Medical University.
Li Q; Department of Pharmacology, Shanxi Medical University.
Wu L; Department of Pharmacology, Shanxi Medical University.
Wang Y; Department of Pharmacology, Shanxi Medical University.

Int Heart J ; 64(2): 283-293, 2023 Mar 31.

Article in En | MEDLINE | ID: mdl-36927931

Subject(s)

Insulin Resistance; Rats; Humans; Animals; Nebivolol/pharmacology; Nebivolol/therapeutic use; Rats, Wistar; Proto-Oncogene Proteins c-akt/metabolism; Phosphatidylinositol 3-Kinases/metabolism; Endothelial Cells/metabolism; Insulin/pharmacology; Endoplasmic Reticulum Stress; Glucose

Key words

GK rats; HAECs; IRS-1/PI3K/Akt/eNOS; TUDCA; Tunicamycin

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Insulin Resistance Type of study: Risk_factors_studies Limits: Animals / Humans Language: En Journal: Int Heart J Journal subject: CARDIOLOGIA Year: 2023 Document type: Article Country of publication: Japan

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google